GUERBET : Financial agenda for 2025
01 November 2024 - 4:00AM
UK Regulatory
GUERBET : Financial agenda for 2025
Financial agenda for 2025
Villepinte, 31 October
2024: Guerbet (FR0000032526 GBT), a
global specialist in contrast agents and solutions for medical
imaging, is announcing its financial agenda for 2025.
|
Publications calendar |
|
February 06, 2025, after trading |
|
March 27, 2025, after trading |
|
April 24, 2025, after trading |
- ANNUAL
SHAREHOLDERS’ MEETING
May 23, 2025 |
|
July 24, 2025, after trading |
|
September 25, 2025, after trading |
|
October 23, 2025, after trading |
About Guerbet
At Guerbet, we build lasting relationships so
that we enable people to live better. That is our purpose. We are a
leader in medical imaging worldwide, offering a comprehensive range
of pharmaceutical products, medical devices, and digital and AI
solutions for diagnostic and interventional imaging. A pioneer in
contrast media for 95 years, with more than 2,600 employees
worldwide, we continuously innovate and devote 10% of our sales to
research and development in four centres in France, in United
States and Israël. Guerbet (GBT) is listed on Euronext Paris
(segment B – mid caps) and generated €786 million in revenue in
2023.
Contacts:
Guerbet
Jérôme Estampes, Chief Financial Officer + 33 1 45 91 50 00 /
jerome.estampes@guerbet.com
Christine Allard, Head of Public Affairs and Communications: +33 6
30 11 57 82 / christine.allard@guerbet.com
Seitosei.Actifin
Marianne Py, Financial Communication + 33 1 80 48 25 31 /
marianne.py@seitosei-actifin.com
Jennifer Jullia, Press +33 1 56 88 11 19 /
jennifer.jullia@seitosei-actifin.com
- GUERBET_Agenda financier 2025 EN
Guerbet (LSE:0ELV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Guerbet (LSE:0ELV)
Historical Stock Chart
From Nov 2023 to Nov 2024
